Sex differences in patients undergoing heart transplantation and LVAD therapy

References

• Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):E895–E1032.
   PubMed Web of Science ®Google Scholar
• Stramba-Badiale M. Women and research on cardiovascular diseases in Europe: a report from the European Heart Health Strategy (EuroHeart) project. Eur Heart J. 2010;31(14):1677–1681.
   Web of Science ®Google Scholar
• Maas AHEM, Van Der Schouw YT, Regitz-Zagrosek V, et al. Red alert for women’s heart: the urgent need for more research and knowledge on cardiovascular disease in womenProceedings of the Workshop held in Brussels on Gender Differences in Cardiovascular disease, 29 September 2010. Eur Heart J. 2011;32(11):1362–1368.
   PubMed Web of Science ®Google Scholar
• Lam CSP, Arnott C, Beale AL, et al. Sex differences in heart failure. Eur Heart J. 2019;40(47):3859–3868c.
   PubMed Web of Science ®Google Scholar
• Khush KK, Hsich E, Potena L, et al. The international thoracic organ transplant registry of the international society for heart and lung Transplantation: thirty-eighth adult heart transplantation report – 2021; Focus on recipient characteristics. J Heart Lung Transplant. 2021;40:1035–1049.
   PubMedGoogle Scholar
• Herr JJ, Ravichandran A, Sheikh FH, et al. Practices of referring patients to advanced heart failure centers. J Card Fail. 2021;27(11):1251–1259.
   PubMed Web of Science ®Google Scholar
• Morris AA, Khazanie P, Drazner MH, et al. Guidance for timely and appropriate referral of patients with advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2021;144(15):E238–E250.
   PubMed Web of Science ®Google Scholar
• Zafar F, Villa CR, Morales DL, et al. Does Small size matter with continuous flow devices?: Analysis of the INTERMACS database of adults with bSA ≤1.5 m2. JACC Hear Fail. 2017;5(2):123–131.
   PubMed Web of Science ®Google Scholar
• Miller LW, Rogers JG. Evolution of left ventricular assist device therapy for advanced heart failure: a review. JAMA Cardiol. 2018;3(7):650–658.
   PubMed Web of Science ®Google Scholar
• Hsich EM. Does size matter with continuous left ventricular assist devices?. JACC Hear Fail. 2017;5(2):132–135.
   PubMed Web of Science ®Google Scholar
• Joshi AA, Lerman JB, Sajja AP, et al. Sex-based differences in left ventricular assist device utilization: insights from the nationwide inpatient sample 2004 to 2016. Circ Heart Fail. 2019;12(9):e006082.
   PubMed Web of Science ®Google Scholar
• Gruen J, Caraballo C, Miller PE, et al. Sex differences in patients receiving left ventricular assist devices for end-stage heart failure. JACC Hear Fail. 2020;8(9):770–779.
   PubMed Web of Science ®Google Scholar
• Shah P, Yuzefpolskaya M, Hickey GW, et al. Twelfth interagency registry for mechanically assisted circulatory support report: readmissions after left ventricular assist device. The Annals of Thoracic Surgery. 2022;113(3):722–737.
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Naftel DC, Stevenson LW, et al. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant. 2008;27(10):1065–72.
   PubMed Web of Science ®Google Scholar
• DeFilippis EM, Truby LK, Garan AR, et al. Sex-related differences in use and outcomes of left ventricular assist devices as bridge to transplantation. JACC Hear Fail. 2019;7(3):250–257.
   PubMed Web of Science ®Google Scholar
• Habal MV, Axsom K, Farr M. Advanced therapies for advanced heart failure in women. Heart Fail Clin. 2019 Jan;15(1):97–107.
   PubMed Web of Science ®Google Scholar
• Tmmh B, Kmm A, de By T MMH, et al. The European Registry for Patients with Mechanical Circulatory Support of the European Association for Cardio-Thoracic Surgery: third report. Eur J Cardio Thoracic Surg. 2022;62:32.
   Web of Science ®Google Scholar
• Kinugawa K, Nishimura T, Toda K, et al. The second official report from Japanese registry for mechanical assisted circulatory support (J-MACS): first results of bridge to bridge strategy. Gen Thorac Cardiovasc Surg. 2020;68(2):102–111.
   PubMed Web of Science ®Google Scholar
• Ono M. Durable ventricular assist device for bridge to transplantation. Heart Transplantation: New Insights in Therapeutic Strategies. 2022.
   Google Scholar
• Milano CA, Rogers JG, Tatooles AJ, et al. HVAD: the ENDURANCE supplemental trial. JACC Hear Fail. 2018;6(9):792–802.
   PubMed Web of Science ®Google Scholar
• Aaronson KD, Slaughter MS, Miller LW, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125(25):3191–3200.
   PubMed Web of Science ®Google Scholar
• Slaughter MS, Pagani FD, McGee EC, et al. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. J Heart Lung Transplant. 2013;32(7):675–683.
   PubMed Web of Science ®Google Scholar
• Estep JD, Starling RC, Horstmanshof DA, et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study. J Am Coll Cardiol. 2015;66(16):1747–1761.
   PubMed Web of Science ®Google Scholar
• Cascino TM, Somanchi S, Colvin M, et al. Racial and sex inequities in the use of and outcomes after left ventricular assist device implantation among medicare beneficiaries. JAMA Network Open. 2022;5(7):e2223080–e2223080.
   PubMed Web of Science ®Google Scholar
• DEFILIPPIS EM, TRUBY LK, CLERKIN KJ, et al. Increased opportunities for transplantation for women in the new heart allocation system. J Card Fail. 2022;28(7):1149–1157.
   PubMed Web of Science ®Google Scholar
• Golbus JR, Gupta K, Colvin M, et al. Changes in type of temporary mechanical support device use under the new heart allocation policy. Circulation. 2020;142(16):1602–1604.
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Xie R, Cowger J, et al. Second annual report from the ISHLT mechanically assisted circulatory support registry. J Heart Lung Transplant. 2018;37(6):685–691.
   PubMed Web of Science ®Google Scholar
• Magnussen C, Bernhardt AM, Ojeda FM, et al. Gender differences and outcomes in left ventricular assist device support: the European Registry for Patients with Mechanical Circulatory Support. J Heart Lung Transplant. 2018;37(1):61–70.
   PubMed Web of Science ®Google Scholar
• Nayak A, Hu Y, Ko YA, et al. Gender differences in mortality after left ventricular assist device implant: a causal mediation analysis approach. ASAIO J. 2021;67(6):614–621.
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Pagani FD, Kormos RL, et al. Eighth annual INTERMACS report: special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017;36(10):1080–1086.
   PubMed Web of Science ®Google Scholar
• Meehan K, Labuhn C, Kagan V, et al. Sex differences in characteristics and outcomes following heartmate 3 left ventricular assist device implantation. J Heart Lung Transplant. 2020;39(4):S337.
   Web of Science ®Google Scholar
• Mehra MR, Naka Y, Uriel N, et al. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2017;376(5):440–450.
   PubMed Web of Science ®Google Scholar
• Goldstein DJ, Mehra MR, Naka Y, et al. Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. J Heart Lung Transplant. 2018;37(1):7–14.
   PubMed Web of Science ®Google Scholar
• Mehra MR, Uriel N, Naka Y, et al. A fully magnetically levitated left ventricular assist device. Final Report N Engl J Med. 2019;380(17):1618–1627.
   PubMed Web of Science ®Google Scholar
• Mehra MR, Cleveland JC, Uriel N, et al. Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMat 3 left ventricular assist device implants. Eur J Heart Fail. 2021;23(8):1392–1400.
   PubMed Web of Science ®Google Scholar
• Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361(23):2241–2251.
   PubMed Web of Science ®Google Scholar
• Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. The New England Journal of Medicine. 2001;345(20):1435–1443.
   PubMed Web of Science ®Google Scholar
• Bourque K, Cotter C, Dague C, et al. Design rationale and preclinical evaluation of the heartmate 3 left ventricular assist system for hemocompatibility. ASAIO J. 2016;62(4):375–383.
   PubMed Web of Science ®Google Scholar
• Li T, Mariani S, Bounader K, et al. Is there a sex gap in outcomes of comparable patients supported with left ventricular assist devices? Artif Organs. 2022;00:1–11.
   Google Scholar
• Matsumoto Y, Fukushima S, Shimahara Y, et al. Sex differences in continuous-flow ventricular assist device therapy for advanced heart failure. Gen Thorac Cardiovasc Surg. 2021;69(6):919–925.
   PubMed Web of Science ®Google Scholar
• Maukel LM, Weidner G, Beyersmann J, et al. Sex differences in recovery and device replacement after left ventricular assist device implantation as destination therapy. J Am Heart Assoc. 2022;11(5):23294.
   Web of Science ®Google Scholar
• Weymann A, Patil NP, Sabashnikov A, et al. Gender differences in continuous-flow left ventricular assist device therapy as a bridge to transplantation: a risk-adjusted comparison using a propensity score-matching analysis. Artif Organs. 2015;39(3):212–219.
   PubMed Web of Science ®Google Scholar
• Tahsili-Fahadan P, Curfman DR, Davis AA, et al. Cerebrovascular events after continuous-flow left ventricular assist devices. Neurocritical Care. 2018;29(2):225–232.
   PubMed Web of Science ®Google Scholar
• Molina EJ, Shah P, Kiernan MS, et al. The Society of Thoracic Surgeons Intermacs 2020 annual report. Ann Thorac Surg. 2021;111(3):778–792.
   PubMed Web of Science ®Google Scholar
• Frontera JA, Starling R, Cho SM, et al. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. J Heart Lung Transplant. 2017;36(6):673–683.
   PubMed Web of Science ®Google Scholar
• REZA N, EDWARDS JJ, Katcoff H, et al. Sex differences in left ventricular assist device-related emergency department encounters in the United States. J Card Fail. 2022;28(9):1445–1455.
   PubMed Web of Science ®Google Scholar
• Bogaev RC, Pamboukian SV, Moore SA, et al. Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation. J Heart Lung Transplant. 2011;30(5):515–522.
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Naftel DC, Myers SL, et al. Quantifying the impact from stroke during support with continuous flow ventricular assist devices: an STS INTERMACS analysis. J Heart Lung Transplant. 2020;39(8):782–794.
   PubMed Web of Science ®Google Scholar
• Sherazi S, Kutyifa V, McNitt S, et al. Effect of gender on the risk of neurologic events and subsequent outcomes in patients with left ventricular assist devices. Am J Cardiol. 2017;119(2):297–301.
   PubMed Web of Science ®Google Scholar
• Acharya D, Loyaga-Rendon R, Morgan CJ, et al. INTERMACS analysis of stroke during support with continuous-flow left ventricular assist devices: risk factors and outcomes. JACC Heart Fail. 2017;5(10):703–711.
   PubMed Web of Science ®Google Scholar
• Morris AA, Pekarek A, Wittersheim K, et al. Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device. J Heart Lung Transplant. 2015;34(12):1570–1577.
   PubMed Web of Science ®Google Scholar
• Boyle AJ, Jorde UP, Sun B, et al. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. J Am Coll Cardiol. 2014;63(9):880–888.
   PubMedGoogle Scholar
• Parikh NS, Cool J, Karas MG, et al. Stroke risk and mortality in patients with ventricular assist devices. Stroke. 2016;47(11):2702–2706.
   PubMed Web of Science ®Google Scholar
• Hsich EM, Naftel DC, Myers SL, et al. Should women receive left ventricular assist device support? Findings from INTERMACS. Circ Hear Fail. 2012;5(2):234–240.
   PubMed Web of Science ®Google Scholar
• van Asch CJ, Luitse MJ, Rinkel GJ, et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167–176.
   PubMed Web of Science ®Google Scholar
• Kawabori M, Conyer RT, Kurihara C, et al. Fatal neurologic dysfunction during continuous-flow left ventricular assist device support. Ann Thorac Surg. 2019;107(4):1132–1138.
   PubMed Web of Science ®Google Scholar
• Rogers JG, Pagani FD, Tatooles AJ, et al. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med. 2017;376(5):451–460.
   PubMed Web of Science ®Google Scholar
• Medtronic stops distribution and sale of heartWare HVAD system due to risk of neurological adverse events, mortality, and potential failure to restart | FDA [Internet]. cited 2022 Jul 7]. Available from 2022 Jul 7: https://www.fda.gov/medical-devices/medical-device-recalls/medtronic-stops-distribution-and-sale-heartware-hvad-system-due-risk-neurological-adverse-events.
   Google Scholar
• Mehra MR, Goldstein DJ, Uriel N, et al. Two-year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med. 2018;378(15):1386–1395.
   PubMed Web of Science ®Google Scholar
• Hall SA, Copeland H, Alam A, et al. The “right” definition for post–left ventricular assist device right heart failure: the more we learn, the less we know. Front Cardiovasc Med. 2022;9:962.
   Web of Science ®Google Scholar
• J van M, Maltais S, Dunlay SM, et al. A multi-institutional outcome analysis of patients undergoing left ventricular assist device implantation stratified by sex and race. J Heart Lung Transplant. 2017;36(1):64–70.
   PubMed Web of Science ®Google Scholar
• Patel CB, Blue L, Cagliostro B, et al. Left ventricular assist systems and infection-related outcomes: a comprehensive analysis of the MOMENTUM 3 trial. J Heart Lung Transplant. 2020;39(8):774–781.
   PubMed Web of Science ®Google Scholar
• LaRue S, Shanks A, Wang IW, et al. Left ventricular assist device in pregnancy. Obstet Gynecol. 2011;118(2):426–428.
   PubMed Web of Science ®Google Scholar
• Yadalam A, Yoo B, Bhatia-Patel S, et al. Successful pregnancy with heartmate 3 (Abbott) left ventricular assist device. J Heart Lung Transplant. 2022;41(4):S345–S346.
   PubMed Web of Science ®Google Scholar
• Malik A, Winchester ML, Gorman K, et al. Left ventricular assist device in pregnancy: case report and review of the literature. J Obstet Gynaecol Res. 2021;47(4):1589–1593.
   PubMed Web of Science ®Google Scholar
• Vargas A, Armin S, Yeomans E. Successful pregnancy with left ventricular assist device failure in the setting of peripartum cardiomyopathy. Proc (Bayl Univ Med Cent). 2021;35(1):98–100.
   PubMedGoogle Scholar
• Sims DB, Vink J, Uriel N, et al. A successful pregnancy during mechanical circulatory device support. J Heart Lung Transplant. 2011;30(9):1065–1067.
   PubMed Web of Science ®Google Scholar
• Makdisi G, Jan MY, Dungy-Poythress L, et al. Successful delivery in a patient with left ventricular assist device and unplanned pregnancy. Ann Thorac Surg. 2017;104(1):e31–e33.
   PubMed Web of Science ®Google Scholar
• Dehkordi S, Abicht T, Lippmann M, et al. SUCCESSFUL PREGNANCY AND DELIVERY WITH CENTRIFUGAL FLOW LEFT VENTRICULAR ASSIST DEVICE. J Am Coll Cardiol. 2020;75(11):2569.
   Web of Science ®Google Scholar
• Defilippis E. M, Haythe J. H, Walsh M. N, et al. Intersection of Heart Failure and Pregnancy: Beyond Peripartum Cardiomyopathy. Circulation. Heart failure . 2021;14(5):e008223.
   PubMed Web of Science ®Google Scholar
• Colvin M, Smith JM, Ahn Y, et al. OPTN/SRTR 2020 annual data report: heart. Am J Transplant. 2022;22(S2):350–437.
   PubMedGoogle Scholar
• Chang PP, Chambless LE, Shahar E, et al. Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the atherosclerosis risk in communities study). Am J Cardiol. 2014;113(3):504–510.
   PubMed Web of Science ®Google Scholar
• Stevenson LW, Kormos RL, Young JB, et al. Major advantages and critical challenge for the proposed United States heart allocation system. J Heart Lung Transplant. 2016;35(5):547–549.
   PubMed Web of Science ®Google Scholar
• Hsich EM, Blackstone EH, Thuita L, et al. Sex differences in mortality based on united network for organ sharing status while awaiting heart transplantation. Circ Hear Fail. 2017;10(6):e003635.
   PubMed Web of Science ®Google Scholar
• Davis MR, Lee CS, Corcoran A, et al. Gender differences in the prevalence of frailty in heart failure: a systematic review and meta-analysis. Int J Cardiol. 2021;333:133–140.
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V, Petrov G, Lehmkuhl E, et al. Heart transplantation in women with dilated cardiomyopathy. Transplantation. 2010;89(2):236–244.
   PubMed Web of Science ®Google Scholar
• Baumhäkel M, Müller U, Böhm M. Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail. 2009;11(3):299–303.
   PubMed Web of Science ®Google Scholar
• Moayedi Y, Fan CPS, Cherikh WS, et al. Survival outcomes after heart transplantation: does recipient sex matter? Circ Hear Fail. 2019;12(10):e006218.
   PubMed Web of Science ®Google Scholar
• Breathett K, Yee E, Pool N, et al. Association of gender and race with allocation of advanced heart failure therapies. JAMA Network Open. 2020;3(7):e2011044–e2011044.
   PubMed Web of Science ®Google Scholar
• Steinberg RS, Nayak A, O’Connell C, et al. Sex differences in eligibility for advanced heart failure therapies. Clin Transplant. 2020;34(5). DOI:10.1111/ctr.13839.
   PubMed Web of Science ®Google Scholar
• Colvin M, Smith JM, Hadley N, et al. OPTN/SRTR 2017 annual data report: heart. Am J Transplant. 2019;19:323–403.
   PubMed Web of Science ®Google Scholar
• National data - OPTN [Internet]. cited 2022 Aug 13]. Available from 2022 Aug 13: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/#.
   Google Scholar
• González-Vílchez F, Gómez-Bueno M, Almenar-Bonet L, et al. Spanish Heart Transplant Registry. 33rd official report of the Heart Failure Association of the Spanish Society of Cardiology. Rev Española Cardiol. English Ed, 2022;75:923–932.
   Web of Science ®Google Scholar
• Organ specific reports - ODT Clinical - NHS Blood and Transplant [Internet]. cited 2022 Nov 10]. Available from 2022 Nov 10: https://www.odt.nhs.uk/statistics-and-reports/organ-specific-reports/.
   Google Scholar
• Reed EF, Demetris AJ, Hammond E, et al. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant. 2006;25(2):153–159.
   PubMed Web of Science ®Google Scholar
• Colvin MM, Cook JL, Chang PP, et al. Sensitization in heart transplantation: emerging knowledge: a scientific statement from the American Heart Association. Circulation. 2019;139(12):e553–e578.
   PubMed Web of Science ®Google Scholar
• Vieira JL, Mehra MR. Heart transplantation candidacy. Curr Opin Organ Transplant. 2021;26(1):69–76.
   PubMed Web of Science ®Google Scholar
• Lietz K, John R, Kocher A, et al. Increased prevalence of autoimmune phenomena and greater risk for alloreactivity in female heart transplant recipients. Circulation. 2001;104(suppl_1). DOI:10.1161/circ.104.suppl_1.I-177.
   PubMedGoogle Scholar
• Grupper A, Nestorovic EM, Daly RC, et al. Sex related differences in the risk of antibody-mediated rejection and subsequent allograft vasculopathy post-heart transplantation: a single-center experience. Transplant Direct. 2016;2(10):E106.
   PubMedGoogle Scholar
• Lau A, West L, Tullius SG. The impact of sex on alloimmunity. Trends Immunol. 2018;39(5):407–418.
   PubMed Web of Science ®Google Scholar
• Nwakanma LU, Williams JA, Weiss ES, et al. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg. 2007;84(5):1556–1563.
   PubMed Web of Science ®Google Scholar
• Morris AA, Cole RT, Laskar SR, et al. Improved outcomes for women on the heart transplant wait list in the modern era. J Card Fail. 2015;21(7):555–560.
   PubMed Web of Science ®Google Scholar
• MacGowan GA, McDiarmid A, Jansen K, et al. Gender differences in the assessment, decision-making and outcomes for ventricular assist devices and heart transplantation: an analysis from a UK transplant center. Clin Transplant. 2022;36(6):e14666.
   PubMed Web of Science ®Google Scholar
• Topkara VK, Sayer GT, Clerkin KJ, et al. Recovery With temporary mechanical circulatory support while waitlisted for heart transplantation. J Am Coll Cardiol. 2022;79(9):900–913.
   PubMed Web of Science ®Google Scholar
• Pober JS, Chih S, Kobashigawa J, et al. Cardiac allograft vasculopathy: current review and future research directions. Cardiovasc Res. 2021;117(13):2624–2638.
   PubMed Web of Science ®Google Scholar
• Chih S, Chong AY, Mielniczuk LM, et al. Allograft vasculopathy the achilles’ heel of heart transplantation. J Am Coll Cardiol. 2016;68(1):80–91.
   PubMed Web of Science ®Google Scholar
• Moayedi Y, Fan CPS, Tremblay-Gravel M, et al. Risk factors for early development of cardiac allograft vasculopathy by intravascular ultrasound. Clin Transplant. 2020;34(11):e14098.
   PubMed Web of Science ®Google Scholar
• Fluschnik N, Geelhoed B, Becher PM, et al. Non-immune risk predictors of cardiac allograft vasculopathy: results from the U.S. organ procurement and transplantation network. Int J Cardiol. 2021;331:57–62.
   PubMed Web of Science ®Google Scholar
• Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report — 2019; focus theme: donor and recipient size match. The Journal of Heart and Lung Transplantation. 2019;38(10):1056–1066.
   PubMedGoogle Scholar
• Hickey KT, Doering LV, Chen B, et al. Clinical and gender differences in heart transplant recipients in the NEW HEART study. Eur J Cardiovasc Nurs. 2017;16(3):222–229.
   PubMed Web of Science ®Google Scholar
• Chang D, Kittleson M, Patel E, et al. Do Women Truly Have Less Than Optimal Outcome Post-Heart Transplantation Compared to Men J Heart Lung Transplant. 2022;41(4):S333–S334.
   Web of Science ®Google Scholar
• Prendergast TW, Furukawa S, Beyer AJ, et al. The role of gender in heart transplantation. Ann Thorac Surg. 1998;65(1):88–94.
   PubMed Web of Science ®Google Scholar
• Jalowiec A, Grady KL, White-Williams C. Mortality, rehospitalization, and post-transplant complications in gender-mismatched heart transplant recipients. Hear Lung. 2017;46(4):265–272.
   PubMed Web of Science ®Google Scholar
• Hong KN, Iribarne A, Worku B, et al. Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg. 2011;92(2):520–527.
   PubMed Web of Science ®Google Scholar
• Khush K K, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult heart transplantation report—2018; Focus Theme: multiorgan Transplantation. J Heart Lung Transplant. 2018;37:1155–1168.
   PubMedGoogle Scholar
• Delgado JF, Alonso-Pulpón L, Mirabet S, et al. Cancer incidence in heart transplant recipients with previous neoplasia history. Am J Transplant. 2016;16(5):1569–1578.
   PubMed Web of Science ®Google Scholar
• Crespo-Leiro MG, Alonso-Pulpón L, Vázquez De Prada JA, et al. Malignancy after heart transplantation: incidence, prognosis and risk factors. Am J Transplant. 2008;8(5):1031–1039.
   PubMed Web of Science ®Google Scholar
• Minguito-Carazo C, Gómez-Bueno M, Almenar-Bonet L, et al. Malignancy following heart transplantation: differences in incidence and prognosis between sexes – a multicenter cohort study. Transpl Int. 2021;34(5):882–893.
   PubMed Web of Science ®Google Scholar
• Carbone D. Smoking and cancer. Am J Med. 1992;93(1):S13–S17.
   PubMedGoogle Scholar
• Momper JD, Misel ML, McKay DB. Sex differences in transplantation. Transplant Rev. 2017;31(3):145–150.
   Web of Science ®Google Scholar
• Hsich E, Singh TP, Cherikh WS, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-ninth adult heart transplantation report — 2022 focus on transplant for restrictive heart disease. J Heart Lung Transplant. 2022;41(10):1366–1375.
   PubMedGoogle Scholar
• Banchs HL, González V, González Cancel I, et al. Heart transplantation in females: the experience in Puerto Rico. Bol Asoc Med P R. 2005;97(4):248–256.
   PubMedGoogle Scholar
• Kleina SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg. 2015;109(1):9–15.
   PubMed Web of Science ®Google Scholar
• Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(16):626–638.
   PubMedGoogle Scholar
• Tsai FC, Marelli D, Bresson J, et al. Recent trends in early outcome of adult patients after heart transplantation: a single-institution review of 251 transplants using standard donor organs. Am J Transplant. 2002;2(6):539–545.
   PubMed Web of Science ®Google Scholar
• Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report—2006. J Heart Lung Transplant. 2006;25(8):869–879.
   PubMedGoogle Scholar
• Hsich EM, Blackstone EH, Thuita LW, et al. Heart transplantation: an in-depth survival analysis. JACC Hear Fail. 2020;8(7):557–568.
   PubMed Web of Science ®Google Scholar
• Morgan AE, Dewey E, Mudd JO, et al. The role of estrogen, immune function and aging in heart transplant outcomes. Am J Surg. 2019;218(4):737–743.
   PubMed Web of Science ®Google Scholar
• Grady KL, Naftel DC, Young JB, et al. Patterns and predictors of physical functional disability at 5 to 10 years after heart transplantation. J Heart Lung Transplant. 2007;26(11):1182–1191.
   PubMed Web of Science ®Google Scholar
• Rybarczyk B, Grady KL, Naftel DC, et al. Emotional adjustment 5 years after heart transplant: a multisite study. Rehabil Psychol. 2007;52(2):206.
   Web of Science ®Google Scholar
• Jalowiec A, Grady KL, White-Williams C. Gender and age differences in symptom distress and functional disability one year after heart transplant surgery. Hear Lung. 2011;40(1):21–30.
   PubMed Web of Science ®Google Scholar
• Reyes CJ, Evangelista LS, Doering L, et al. Physical and psychological attributes of fatigue in female heart transplant recipients. J Heart Lung Transplant. 2004;23(5):614–619.
   PubMed Web of Science ®Google Scholar
• Kaczmarek I, Meiser B, Beiras-Fernandez A, et al. Gender does matter: gender-specific outcome analysis of 67,855 heart transplants. Thorac Cardiovasc Surg. 2013;61(1):29–36.
   PubMed Web of Science ®Google Scholar
• Kirsch M, Baufreton C, Naftel DC, et al. Pretransplantation risk factors for death after heart transplantation: the Henri Mondor experience. J Heart Lung Transplant. 1998;17(3):268–277.
   PubMed Web of Science ®Google Scholar
• Khush KK, Kubo JT, Desai M. Influence of donor and recipient sex mismatch on heart transplant outcomes: analysis of the International Society of Heart and Lung Transplantation registry. J Heart Lung Transplant. 2012;31(5):459–466.
   PubMed Web of Science ®Google Scholar
• Weiss ES, Allen JG, Patel ND, et al. The impact of donor-recipient sex matching on survival after orthotopic heart transplantation: analysis of 18 000 transplants in the modern era. Circ Hear Fail. 2009;2(5):401–408.
   PubMed Web of Science ®Google Scholar
• Bergenfeldt H, Stehlik J, Höglund P, et al. Donor–recipient size matching and mortality in heart transplantation: influence of body mass index and gender. J Heart Lung Transplant. 2017;36(9):940–947.
   PubMed Web of Science ®Google Scholar
• Al-Khaldi A, Oyer PE, Robbins RC. Outcome analysis of donor gender in heart transplantation. J Heart Lung Transplant. 2006;25(4):461–468.
   PubMed Web of Science ®Google Scholar
• Ayesta A, Urrútia G, Madrid E, et al. Sex-mismatch influence on survival after heart transplantation: a systematic review and meta-analysis of observational studies. Clin Transplant. 2019;33(12):e13737.
   PubMed Web of Science ®Google Scholar
• Reed RM, Netzer G, Hunsicker L, et al. Cardiac size and sex-matching in heart transplantation: size matters in matters of sex and the heart. JACC Hear Fail. 2014;2(1):73–83.
   PubMed Web of Science ®Google Scholar
• Punnoose LR, Coscia LA, Armenti DP, et al. Pregnancy outcomes in heart transplant recipients. J Heart Lung Transplant. 2020;39(5):473–480.
   PubMed Web of Science ®Google Scholar
• Costanzo MR, Dipchand A, Starling R, et al. The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29:914–956.
   PubMed Web of Science ®Google Scholar
• Douglas NC, Shah M, Sauer MV. Fertility and reproductive disorders in female solid organ transplant recipients. Semin Perinatol. 2007;31(6):332–338.
   PubMed Web of Science ®Google Scholar
• Defilippis EM, Kittleson MM. Pregnancy after heart transplantation. J Card Fail. 2021;27(2):176–184.
   PubMed Web of Science ®Google Scholar
• Cirillo D, Catuara-Solarz S, Morey C, et al. Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare. NPJ Digit Med. 2020;3:3.
   PubMed Web of Science ®Google Scholar
• New and revised requirements to reduce health care disparities | the joint commission [Internet]. cited 2022 Nov 7]. Available from 2022 Nov 7: https://www.jointcommission.org/standards/prepublication-standards/new-and-revised-requirements-to-reduce-health-care-disparities/
   Google Scholar